Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, Sunho Biologics Inc increased its cash reserves by 6,768.42%, or 123.25m. Cash Flow from Financing totalled 255.50m or -- of revenues. In addition the company used 40.65m for operations while cash used for investing totalled 83.89m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.85 |
---|---|
Tangible book value per share | 3.78 |
More ▼
Balance sheet in CNYView more
Current ratio | 14.80 |
---|---|
Quick ratio | 14.77 |
Total debt/total equity | 0.0544 |
---|---|
Total debt/total capital | 0.0516 |
More ▼